CAL
KLDO

Capital Advisors Ltd’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Capital Advisors Ltd’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-132
Closed – – 1467
2022
Q1 		$0 Buy
+132
New +$235 ﹤0.01% 1323

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Capital Advisors Ltd's KLDO Position: Q2 2022 in Review

Capital Advisors Ltd sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 132 shares.

Capital Advisors Ltd first reported a position in KLDO in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Capital Advisors Ltd reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Capital Advisors Ltd sold 132 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
  • Capital Advisors Ltd first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Capital Advisors Ltd's Kaleido Biosciences, Inc. Common Stock position peaked at $0 in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Capital Advisors Ltd's 13F filing for Q2 2022, filed 5 Aug 2022.